Skip to content

Feasibility of the "Clip with Line Pulley Securing (CLiPS)" Technique for Closure After Colorectal ESD: A Prospective Study

Feasibility of the "Clip with Line Pulley Securing (CLiPS)" Technique for Closure After Colorectal ESD: A Prospective Study - C-CLiPS Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000057849
Enrollment
50
Registered
2025-05-13
Start date
2025-05-15
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Tumor

Interventions

Post-colorectal ESD defects is approximated by the CLiPS technique, which involves pulling the mucosa together with a clip-line and securing with an endoloop.

Sponsors

NTT Medical Center Tokyo
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion Criteria Age over 20 years at registration. ECOG Performance Status of 0 or 1. Lesion size between 20-50 mm. The most recent blood test within 30 days prior to registration meets all of the following criteria (no blood transfusion within 14 days prior to the test used for registration) Hemoglobin over 9 g/dL Platelet count above 100,000 AST/ALT below 100 Serum creatinine below 2.0 mg/dL Able to be followed for 28 days after treatment. Written informed consent has been obtained.

Exclusion criteria

Exclusion criteria: Exclusion Criteria History of endoscopic treatment for lower gastrointestinal lesions within 28 days prior to enrollment. Planned endoscopic treatment for the lower gastrointestinal tract within 28 days after the procedure. Planned treatment of multiple lesions at the same time. Presence of active inflammatory bowel disease (ulcerative colitis or Crohn's disease). History of radiation therapy to the planned ESD area. Women who are possibly pregnant, currently pregnant, or breastfeeding. Presence of psychiatric conditions that impair understanding of the study. History of myocardial infarction or unstable angina within the past 3 months. Presence of a coagulation disorder (regardless of antithrombotic medication use). Active bacterial or fungal infection (defined as fever over 38.5 degrees with supporting radiologic or microbiological evidence). Presence of respiratory disease requiring continuous oxygen therapy. Uncontrolled hypertension. Any other condition deemed inappropriate for study participation by the investigator.

Design outcomes

Primary

MeasureTime frame
Complete Closure rate

Secondary

MeasureTime frame
1. Evaluation of the Closure Technique (Time required for defect closure,Types and number of devices used, Procedure-related adverse events) 2. Incidence of Post-closure Adverse Events (Delayed bleeding, Delayed perforation, Other complications) 3. Closure Integrity (Maintenance of defect closure at 2 days post-procedure)

Countries

Japan

Contacts

Public ContactHiroshi Yamazaki

NTT Medical Center Tokyo Gastrointestinal Endoscopy

hiroyama90@hotmail.com03-3448-6111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026